Jennette J.C. Falk R.J. Bacon P.A. et al.

2012 Revised international chapel hill consensus conference nomenclature of vasculitides.

Arthritis Rheum. 65: 1-11Miloslavsky E. Unizony S.

The heart in vasculitis.

Rheum Dis Clin N Am. 40: 11-26

Ischemic complications in Takayasu’s arteritis: a meta-analysis.

Semin Arthritis Rheum. 47: 900-906

Cardiac involvement in primary systemic vasculitis and potential drug therapies to reduce cardiovascular risk.

Rheumatol Int. 37: 151-167Deok Bae Y. Jin Choi H. Chan Lee J. et al.

Clinical features of polyarteritis nodosa in Korea.

J Korean Med Sci. 21: 591-596

Risk of ischaemic heart diseases and stroke in behçet disease: a systematic review and meta-analysis.

Eur J Clin Invest. 52: e13778

Cardiovascular disease due to accelerated atherosclerosis in systemic vasculitides.

Best Pract Res Clin Rheumatol. 27: 33-44Souverein P.C. Berard A. van Staa T.P. et al.

Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case-control study.

Heart. 90: 859-865Hsue P.Y. Scherzer R. Grunfeld C. et al.

Depletion of B-cells with rituximab improves endothelial function and reduces inflammation among individuals with rheumatoid arthritis.

J Am Heart Assoc. 3https://doi.org/10.1161/JAHA.114.001267Micha R. Imamura F. Wyler Von Ballmoos M. et al.

Systematic review and meta-analysis of methotrexate use and risk of cardiovascular disease.

Am J Cardiol. 108: 1362-1370Aghayev A. Steigner M.L. Azene E.M. et al.

ACR appropriateness Criteria® noncerebral vasculitis.

J Am Coll Radiol. 18: S380-S393Chrysidis S. Duftner C. Dejaco C. et al.

Definitions and reliability assessment of elementary ultrasound lesions in giant cell arteritis: a study from the OMERACT large vessel vasculitis ultrasound working group.

RMD Open. 4https://doi.org/10.1136/rmdopen-2017-000598van der Geest K.S.M. Wolfe K. Borg F. et al.

Ultrasonographic Halo Score in giant cell arteritis: association with intimal hyperplasia and ischaemic sight loss.

Rheumatology. 60: 4361-4366Schäfer V.S. Jin L. Schmidt W.A.

Imaging for diagnosis, monitoring, and outcome prediction of large vessel vasculitides.

Curr Rheumatol Rep. 22https://doi.org/10.1007/s11926-020-00955-yvan der Geest K.S.M. Borg F. Kayani A. et al.

Novel ultrasonographic Halo Score for giant cell arteritis: assessment of diagnostic accuracy and association with ocular ischaemia.

Ann Rheum Dis. 79: 393-399Rhéaume M. Rebello R. Pagnoux C. et al.

High-resolution magnetic resonance imaging of scalp arteries for the diagnosis of giant cell arteritis: results of a prospective cohort study.

Arthritis Rheumatol. 69: 161-168Yamada S. Kubota K. Kubota R. et al.

High accumulation of fluorine-18-fluorodeoxyglucose in turpentine-induced inflammatory tissue.

J Nucl Med. 36 (): 1301-1306Mochizuki T. Tsukamoto E. Kuge Y. et al.

FDG uptake and glucose transporter subtype expressions in experimental tumor and inflammation models.

J Nucl Med. 42 (): 1551-1555Jamar F. Buscombe J. Chiti A. et al.

EANM/SNMMI guideline for 18F-FDG use in inflammation and infection.

J Nucl Med. 54: 647-658van der Geest K.S.M. Sandovici M. Brouwer E. et al.

Diagnostic accuracy of symptoms, physical signs, and laboratory tests for giant cell arteritis.

JAMA Intern Med. 180: 1295van Sleen Y. Graver J.C. Abdulahad W.H. et al.

Leukocyte dynamics reveal a persistent myeloid dominance in giant cell arteritis and polymyalgia rheumatica.

Front Immunol. 1 ()https://doi.org/10.3389/fimmu.2019.01981Dejaco C. Ramiro S. Duftner C. et al.

EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice.

Ann Rheum Dis. 77: 636-643Nienhuis P.H. Sandovici M. Glaudemans A.W. et al.

Visual and semiquantitative assessment of cranial artery inflammation with FDG-PET/CT in giant cell arteritis.

Semin Arthritis Rheum. 50: 616-623Nielsen B.D. Hansen I.T. Kramer S. et al.

Simple dichotomous assessment of cranial artery inflammation by conventional 18F-FDG PET/CT shows high accuracy for the diagnosis of giant cell arteritis: a case-control study.

Eur J Nucl Med Mol Imag. 46: 184-193van der Geest K.S.M. van Sleen Y. Nienhuis P. et al.

Comparison and validation of FDG-PET/CT scores for polymyalgia rheumatica.

Rheumatology. 61: 1072-1082Blockmans D. Bley T. Schmidt W.

Imaging for large-vessel vasculitis.

Curr Opin Rheumatol. 21: 19-28Besson F.L. Parienti J.J. Bienvenu B. et al.

Diagnostic performance of 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a systematic review and meta-analysis.

Eur J Nucl Med Mol Imag. 38: 1764-1772Nielsen B.D. Gormsen L.C. Hansen I.T. et al.

Three days of high-dose glucocorticoid treatment attenuates large-vessel 18F-FDG uptake in large-vessel giant cell arteritis but with a limited impact on diagnostic accuracy.

Eur J Nucl Med Mol Imag. 45: 1119-1128Saadoun D. Vautier M. Cacoub P.

Medium- and large-vessel vasculitis.

Circulation. 143: 267-282Sanchez-Alvarez C. Crowson C.S. Koster M.J. et al.

Prevalence of Takayasu arteritis: a population-based study.

J Rheumatol. 48: 952Watts R.A. Hatemi G. Burns J.C. et al.

Global epidemiology of vasculitis.

Nat Rev Rheumatol. 18: 22-34Stone J.R. Bruneval P. Angelini A. et al.

Consensus statement on surgical pathology of the aorta from the society for cardiovascular pathology and the association for European cardiovascular pathology: I. Inflammatory diseases.

Cardiovasc Pathol. 24: 267-278Goel R. Bates Gribbons K. Carette S. et al.

Derivation of an angiographically based classification system in Takayasu’s arteritis: an observational study from India and North America Rheumatology key messages.

Rheumatology. 59: 1118-1127Chung J.W. Kim H.C. Choi Y.H. et al.

Patterns of aortic involvement in Takayasu arteritis and its clinical implications: evaluation with spiral computed tomography angiography.

J Vasc Surg. 45: 906-914Serra R. Butrico L. Fugetto F. et al.

Updates in pathophysiology, diagnosis and management of Takayasu arteritis.

Ann Vasc Surg. 35: 210-225de Souza A.W.S. de Carvalho J.F.

Diagnostic and classification criteria of Takayasu arteritis.

J Autoimmun. 48-49: 79-83Cavalli G. Tomelleri A. di Napoli D. et al.

Prevalence of Takayasu arteritis in young women with acute ischemic heart disease.

Int J Cardiol. 252: 21-23Johnston S.L. Lock R.J. Gompels M.M.

Takayasu arteritis: a review.

J Clin Pathol. 55: 481-486Yu R.Y. AlSolimani R. Khalidi N. et al.

Characteristics of Takayasu arteritis patients with severe ischemic events.

J Rheumatol. 47: 1224-1228Sarma K. Handique A. Phukan P. et al.

Magnetic resonance angiography and multidetector CT angiography in the diagnosis of takayasu’s arteritis: assessment of disease extent and correlation with disease activity.

Current Medical Imaging Formerly Current Medical Imaging Reviews. 18: 51-60Svensson C. Eriksson P. Zachrisson H.

Vascular ultrasound for monitoring of inflammatory activity in Takayasu arteritis.

Clin Physiol Funct Imag. 40: 37-45

The role of 18F fluorodeoxyglucose positron emission tomography scanning in the diagnosis and management of systemic vasculitis.

International Journal of Rheumatic Diseases. 18: 714-724Lee Y.H. Choi S.J. Ji J.D. et al.

Diagnostic accuracy of 18F-FDG PET or PET/CT for large vessel vasculitis.

Z Rheumatol. 75: 924-931

Aortitis.

Circulation. 117: 3039-3051Barwick T.D. OTA Lyons Mikhaeel N.G. et al.

18F-FDG PET-CT uptake is a feature of both normal diameter and aneurysmal aortic wall and is not related to aneurysm size.

Eur J Nucl Med Mol Imag. 41: 2310-2318Treglia G. Stefanelli A. Mattoli M.V. et al.

Usefulness of 18F-FDG PET/CT in evaluating disease activity at different times in a patient with chronic periaortitis.

Nuclear Medicine and Molecular Imaging. 47: 69-71Cinar I. Wang H. Stone J.R.

Clinically isolated aortitis: pitfalls, progress, and possibilities.

Cardiovasc Pathol. 29: 23-32Watts R.A. Lane S.E. Scott D.G.I.

Epidemiology of vasculitis in europe.

Ann Rheum Dis. 60: 1156a-11157aLee P.Y. Aksentijevich I. Zhou Q.

Mechanisms of vascular inflammation in deficiency of adenosine deaminase 2 (DADA2).

Semin Immunopathol. 44: 269-280Guillevin L. Lhote F. Cohen P. et al.

Polyarteritis nodosa related to hepatitis B virus A prospective study with long-term observation of 41 patients.

Medicine. 74: 238-253Matsumoto T. Kobayashi S. Ogishima D. et al.

Isolated necrotizing arteritis (localized polyarteritis nodosa): examination of the histological process and disease entity based on the histological classification of stage and histological differences from polyarteritis nodosa.

Cardiovasc Pathol. 16: 92-97Hernández-Rodríguez J. Alba M.A. Prieto-González S. et al.

Diagnosis and classification of polyarteritis nodosa.

J Autoimmun. 48-49: 84-89Chen Z. Zhao Y. Wang Q. et al.

Imaging features of 18F-FDG PET/CT in different types of systemic vasculitis.

Clin Rheumatol. 41: 1499-1509Bleeker-Rovers C.P. Bredie S.J.H. van der Meer J.W.M. et al.

F-18-fluorodeoxyglucose positron emission tomography in diagnosis and follow-up of patients with different types of vasculitis.

Neth J Med. 61 (): 323-329Fagart A. MacHet T. Collet G. et al.

Fluorodeoxyglucose positron emission tomography-computed tomography findings in a first series of 10 patients with polyarteritis nodosa.

Rheumatology. 61: 1663-1668Holman R.C. Belay E.D. Christensen K.Y. et al.

Hospitalizations for Kawasaki syndrome among children in the United States, 1997-2007.

Pediatr Infect Dis J. 29: 483-488McCrindle B.W. Rowley A.H. Newburger J.W. et al.

Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American heart association.

Circulation. 135https://doi.org/10.1161/CIR.0000000000000484Hoshino S. Tsuda E. Yamada O.

Characteristics and fate of systemic artery aneurysm after Kawasaki disease.

J Pediatr. 167 (): 108-112Danchin M.H. Abo Y. Akikusa J. et al.

FDG-PET imaging in a child with Kawasaki disease: systemic and coronary artery inflammation without dilatation.

Arch Dis Child. 107: 619Yazici Y. Hatemi G. Bodaghi B. et al.

Behçet syndrome.

Nat Rev Dis Prim. 7: 67Yazici H. Seyahi E. Hatemi G. et al.

Behçet syndrome: a contemporary view.

Nature Publishing Group, : 14https://doi.org/10.1038/nrrheum.2017.208Oh S.H. Han E.C. Lee J.H. et al.

Comparison of the clinical features of recurrent aphthous stomatitis and Behçet’s disease.

Clin Exp Dermatol. 34: e208-e212Bayraktar Y. Ozaslan E. van Thiel D.H.

Gastrointestinal manifestations of Behcet’s disease.

J Clin Gastroenterol. 30: 144-154Tugal-Tutkun I. Onal S. Altan-Yaycioglu R. et al.

Uveitis in Behçet disease: an analysis of 880 patients.

Am J Ophthalmol. 138: 373-380Toledo-Samaniego N. Oblitas C.M. Peñaloza-Martínez E. et al.

Arterial and venous involvement in Behçet’s syndrome: a narrative review.

J Thromb Thrombolysis. 54: 162-171Tascilar K. Melikoglu M. Ugurlu S. et al.

Vascular involvement in Behçet’s syndrome: a retrospective analysis of associations and the time course.

Rheumatology. 53: 2018-2022

Intracardiac thrombus in Behçet’s disease: four new cases and a comprehensive literature review.

Rheumatol Int. 35: 1269-1279Saadoun D. Asli B. Wechsler B. et al.

Long-term outcome of arterial lesions in Behçet disease: a series of 101 patients.

Medicine. 91: 18-24Zhou J. Shi J. Liu J. et al.

The clinical features, risk factors, and outcome of aneurysmal lesions in behcet’s disease.

Journal of Immunology Research. 2019: 1-8Cho S bin Yun M. Lee J.H. et al.

Detection of cardiovascular system involvement in behçet’s disease using fluorodeoxyglucose positron emission tomography.

Semin Arthritis Rheum. 40: 461-466Xi X.Y. Gao W. Guo X.J. et al.

Multiple cardiovascular involvements in Behçet’s disease: unique utility of 18F-FDG PET/CT in diagnosis and follow-up.

Eur J Nucl Med Mol Imag. 46: 2210-2211Gluth M.B. Baratz K.H. Matteson E.L. et al.

Cogan syndrome: a retrospective review of 60 patients throughout a half century.

Mayo Clin Proc. 81: 483-488Grasland A. Pouchot J. Hachulla E. et al.

Typical and atypical Cogan’s syndrome: 32 cases and review of the literature.

Rheumatology. 43: 1007-1015Stone J.H. Zen Y. Deshpande V.

IgG4-Related disease.

N Engl J Med. 366: 539-551

FDG PET vascular imaging in IgG4-RD: potential and challenges.

J Nucl Cardiol. 29: 2934-2937Zhang J. Chen H. Ma Y. et al.

Characterizing IgG4-related disease with 18F-FDG PET/CT: a prospective cohort study.

Eur J Nucl Med Mol Imag. 41: 1624-1634Yabusaki S. Oyama-Manabe N. Manabe O. et al.

Characteristics of immunoglobulin G4-related aortitis/periaortitis and periarteritis on fluorodeoxyglucose positron emission tomography/computed tomography co-registered with contrast-enhanced computed tomography.

EJNMMI Res. 7: 20Imai S. Tahara N. Igata S. et al.

Vascular/perivascular inflammation in IgG4-related disease.

J Nucl Cardiol. 29: 2920-2933Carbajal H. Waters L. Popovich J. et al.

IgG4 related cardiac disease.

Methodist DeBakey Cardiovascular Journal. 9: 230Kingdon J. Roscamp J. Sangle S. et al.

Relapsing polychondritis: a clinical review for rheumatologists.

Rheumatology. 57: 1525-1532Foidart J.M. Abe S. Martin G.R. et al.

Antibodies to type II collagen in relapsing polychondritis.

N Engl J Med. 299: 1203-1207Hazra N. Dregan A. Charlton J. et al.

Incidence and mortality of relapsing polychondritis in the UK: a population-based cohort study.

Rheumatology. 54: 2181-2187Horvath A. Pall N. Molnar K. et al.

A nationwide study of the epidemiology of relapsing polychondritis.

Clin Epidemiol. 8: 211-230Alqanatish J.T. Alshanwani J.R.

Relapsing polychondritis in children: a review.

Mod Rheumatol. 30: 788-798Erdogan M. Esatoglu S.N. Hatemi G. et al.

Aortic involvement in relapsing polychondritis: case-based review.

Rheumatol Int. 41: 827-837Tomelleri A. Campochiaro C. Sartorelli S. et al.

Large-vessel vasculitis affecting the aorta and its branches in relapsing polychondritis: case series and systematic review of the literature.

J Rheumatol. 47: 1780-1784Erdogan M. Sinem · Esatoglu N. et al.

CASE BASED REVIEW Aortic involvement in relapsing polychondritis: case-based review.

Rheumatol Int. 41: 827-837Okuda S. Hirooka Y. Itami T. et al.

FDG-PET/CT and auricular cartilage biopsy are useful for diagnosing with relapsing polychondritis in patients without auricular symptoms.

Life. 11: 956Slart R.H.J.A. Glaudemans A.W.J.M. Brouwer E. et al.

Therapy response evaluation in large-vessel vasculitis: a new role for [18F]FDG-PET/CT?.

Rheumatology. 60: 3494-3495van der Geest K.S.M. Treglia & G. Glaudemans A.W.J.M. et al.

Diagnostic value of [18F]FDG-PET/CT for treatment monitoring in large vessel vasculitis: a systematic review and meta-analysis.

Eur J Nucl Med Mol Imag. 48: 3886-3902Schönau V. Roth J. Tascilar K. et al.

Resolution of vascular inflammation in patients with new-onset giant cell arteritis: data from the RIGA study.

Rheumatology. 60: 3851-3861Grayson P.C. Alehashemi S. Bagheri A.A. et al.

18F-Fluorodeoxyglucose-Positron emission tomography as an imaging biomarker in a prospective, longitudinal cohort of patients with large vessel vasculitis.

Arthritis Rheumatol. 70: 439-449Pugliese F. Gaemperli O. Kinderlerer A.R. et al.

Imaging of vascular inflammation with [11C]-PK11195 and positron emission tomography/computed tomography angiography.

J Am Coll Cardiol. 56: 653-661Lamare F. Hinz R. Gaemperli O. et al.

Detection and quantification of large-vessel inflammation with 11C-(R)-PK11195 PET/CT.

J Nucl Med. 52: 33-39Owen D.R. Yeo A.J. Gunn R.N. et al.

An 18-kDa translocator protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28.

J Cerebr Blood Flow Metabol. 32: 1-5Owen D.R.J. Gunn R.N. Rabiner E.A. et al.

Mixed-affinity binding in humans with 18-kDa translocator protein ligands.

J Nucl Med. 52: 24-32Schollhammer R. Lepreux S. Barthe N. et al.

In vitro and pilot in vivo imaging of 18 kDa translocator protein (TSPO) in inflammatory vascular disease.

EJNMMI Res. 11: 45Tarkin J.M. Wall C. Gopalan D. et al.

Novel approach to imaging active Takayasu arteritis using somatostatin receptor positron emission tomography/magnetic resonance imaging circulation: cardiovascular imaging.

Circ Cardiovasc Imaging. 13: 10389Schmidkonz C. Rauber S. Atzinger A. et al.

Disentangling inflammatory from fibrotic disease activity by fibroblast activation protein imaging.

Ann Rheum Dis. 79: 1485-1491Hicks R.J. Roselt P.J. Kallur K.G. et al.

Fapi PET/CT: will it end the hegemony of 18F-FDG in oncology?.

J Nucl Med. 62: 296-302Luo Y. Pan Q. Yang H. et al.

Fibroblast activation protein–targeted PET/CT with 68Ga-FAPI for imaging IgG4-related disease: comparison to 18F-FDG PET/CT.

J Nucl Med. 62: 266-271van der Geest K.S.M. Sandovici M. Nienhuis P.H. et al.

Novel PET imaging of inflammatory targets and cells for the diagnosis and monitoring of giant cell arteritis and polymyalgia rheumatica.

Front Med. 9https://doi.org/10.3389/fmed.2022.902155van Sleen Y. Jiemy W.F. Pringle S. et al.

A distinct macrophage subset mediating tissue destruction and neovascularization in giant cell arteritis: implication of the YKL-40/interleukin-13 receptor α2 Axis.

Arthritis Rheumatol. 73: 2327-2337Jiemy W.F. Sleen Y. Geest K.S. et al.

Distinct macrophage phenotypes skewed by local granulocyte macrophage colony-stimulating factor (GM-CSF) and macrophage colony-stimulating factor (M-CSF) are associated with tissue destruction and intimal hyperplasia in giant cell arteritis.

Clinical & Translational Immunology. 9https://doi.org/10.1002/cti2.1164Bruijnen S. Tsang-A-Sjoe M. Raterman H. et al.

B-cell imaging with zirconium-89 labelled rituximab PET-CT at baseline is associated with therapeutic response 24 weeks after initiation of rituximab treatment in rheumatoid arthritis patients.

Arthritis Res Ther. 18: 266Slart R.H.J.A. Tsoumpas C. Glaudemans A.W.J.M. et al.

Long axial field of view PET scanners: a road map to implementation and new possibilities.

Eur J Nucl Med Mol Imag. 48: 4236-4245Alberts I. Hünermund J.N. Prenosil G. et al.

Clinical performance of long axial field of view PET/CT: a head-to-head intra-individual comparison of the Biograph Vision Quadra with the Biograph Vision PET/CT.

Eur J Nucl Med Mol Imaging. 48: 2395-2404Rodriguez J.A. Selvaraj S. Bravo P.E.

Potential cardiovascular applications of total-body PET imaging.

Pet Clin. 16: 129-136Nienhuis P.H. van Praagh G.D. Glaudemans A.W.J.M. et al.

A review on the value of imaging in differentiating between large vessel vasculitis and atherosclerosis.

J Pers Med. 11 (): 236Slart R.H.J.A. Glaudemans A.W.J.M. Chareonthaitawee P. et al.

FDG-PET/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica: joint procedural recommendation of the EANM, SNMMI, and the PET Interest Group (PIG), and endorsed by the ASNC.

Eur J Nucl Med Mol Imag. 45: 1250-1269